CTS 公司 CTS

Mr. Kieran M. O'Sullivan has been appointed Executive Chairman, effective as of July 6, 2026. Mr. O'Sullivan joined CTS in January 2013 as President and Chief Executive Officer and was appointed Chairman of the Board in May 2014. From 2006 until 2012, Mr. O'Sullivan served in several executive-level roles with Continental A.G., a global business focused on technology solutions and products for the transportation and mobility industries, first serving as Executive Vice President of the Global Infotainment and Connectivity business and later adding responsibility for its NAFTA Interior Division. From 2004 until 2006, Mr. O'Sullivan served as Corporate Vice President of Motorola's Automotive business. Since 2015, Mr. O'Sullivan has been a member of the board of directors of LCI Industries (NYSE: LCII), a supplier of engineered components for manufacturers of recreational vehicles, manufactured homes, marine applications and for related aftermarkets, and currently serves as Chair of the Risk Committee and as a member of the Audit and Corporate Governance, Nominating and Sustainability Committees. On June 25, 2026, CTS Corporation announced that Kieran O'Sullivan, the Company's President and Chief Executive Officer , will be stepping down effective as of July 6, 2026 Mr. O'Sullivan will remain on the Board of Directors of the Company and has been appointed Executive Chairman, effective as of the Effective Date.

Ashish Agrawal - 55 - Vice President and Chief Financial Officer. On November 11, 2013, Mr. Agrawal was elected Vice President and Chief Financial Officer of CTS. Mr. Agrawal joined CTS in June 2011 as Vice President, Treasury and Corporate Development, and was elected as Treasurer on September 1, 2011. Before joining CTS, Mr. Agrawal was with Dometic Group AB, a manufacturer of refrigerators, awnings and air conditioners, as Senior Vice President and Chief Financial Officer, Americas, beginning in 2007. Prior to that, Mr. Agrawal was with General Electric Company in various positions beginning in December 1994.

The Board has appointed Pratik Trivedi as President, Director and CEO of the Company effective on as of July 6, 2026. Mr. Trivedi, has served as the Company's Chief Operating Officer since December 2025. Mr. Trivedi initially joined CTS in April 2024 as Senior Vice President. Immediately prior to joining the Company, Mr. Trivedi served as Vice President, North America for the mobility business of Eaton Corporation plc, a global power management company, since 2017. Prior to that role, Mr. Trivedi served in several key roles with Cummins, Inc., another global power management company.

Mark Pacioni - 60 - Vice President, Chief Legal and Administrative Officer and Secretary. On July 1, 2025, Mr. Pacioni was appointed Chief Legal and Administrative Officer and Corporate Secretary of CTS. Prior to joining CTS, Mr. Pacioni served as Chief Legal Officer and Secretary of CareerBuilder, LLC, a provider of job search engines, talent management software, and other recruitment related services from 2019 to 2024 and its successor company, CareerBuilder + Monster, from 2024 until June 2025. Prior thereto, he held senior legal roles at The Boeing Co., Molex, Inc., and Knowles Corp. In addition to his in-house experience, Mr. Pacioni was in private practice representing public companies on transactions and governance matters and was Special Counsel at the U.S. Securities and Exchange Commission.

Mr. Profusek is a partner with Jones Day, a global law firm, where he serves as Global Chair of M&A. Joining Jones Day in 1975, Mr. Profusek has been recognized as one of the world's leading M&A and corporate governance lawyers. He has worked on hundreds of mergers, acquisitions and restructurings and has advised many boards and director committees on sensitive corporate governance matters. Mr. Profusek has served as an independent director of five public companies, presently serves as a member of the board of directors of Kodiak Sciences, Inc., (NASDAQ: KOD) a biopharmaceutical company specializing in therapeutics to treat chronic, high-prevalence ophthalmic diseases, and currently serves as its Lead Independent Director, Chair of the Nominating and Corporate Governance Committee and as a member of the Compensation Committee. He served as a member of the Board of Directors of Valero Energy from 2005 to 2025 and its Lead Independent Director from 2015 to 2025. Mr. Profusek was included in the Wall Street Journal's inaugural listing of the Top 250 Corporate Directors last year.

Ms. Costello served as Chief Financial Officer of C&D Technologies, Inc., a global leader in energy storage solutions and services for the telecommunications, utility, uninterruptible power supply, cable, broadband and renewable energy markets, from 2016 to 2020. She served as Chief Financial Officer (from 2008 to 2016) and Vice President, Controller and Chief Accounting Officer (from 2002 to 2008) of Sequa Corporation, which, through its subsidiary Chromalloy, is a global technology company and a leading solutions provider for aircraft engines and gas turbines. From 1995 to 2002, Ms. Costello held the role of Senior Manager with Arthur Andersen, LLP. Ms. Costello is a member of the board of directors of Rogers Corporation (NYSE: ROG), a global company focused on specialty materials and components, such as elastomeric materials, specialty silicone and polyurethane materials and pressure sensitive tapes, and currently serves as a member of the Audit Committee. Ms. Costello previously served as a member of the board of directors of Neenah, Inc. (formerly NYSE: NP) and Horizon Global Corporation (formerly NASDAQ: HZN).

Mr. Johnson served as Chief Financial Officer of Cabot Microelectronics Corporation (formerly NASDAQ: CCMP) for almost fifteen years, first as Vice President, from April 2003 until April 2013, and then as Executive Vice President, until January 2018. Mr. Johnson served as Senior Advisor to the Chief Executive Officer from January 2018 until January 2019. Cabot Microelectronics Corporation, later known as CMC Materials, Inc., and now a wholly owned subsidiary of Entegris, Inc. (NASDAQ: ENTG), is a leading supplier of advanced materials primarily for the semiconductor industry. From August 2000 until March 2003, Mr. Johnson served as Executive Vice President and Chief Financial Officer of Budget Group, Inc. (formerly NYSE: BD), the globally recognized car rental company, now a part of the Avis Budget Group (NASDAQ: CAR). From 1983 to 1999, Mr. Johnson served in various finance and management roles of increasing responsibility with BP Amoco (NYSE: BP), the global oil, gas and chemical company. Mr. Johnson currently serves as a member of the advisory board of Waldom Electronics, a master distributor of electronic and electrical components.

Mr. Stone served as Executive Vice President of Laboratory Solutions for Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the biopharma and healthcare, education and government and advanced technologies industries, until July 2024. Avantor's Laboratory Solutions segment is a multi-billion-dollar business that includes a comprehensive portfolio of products, services and digital solutions to enable insights in life sciences research, diagnostic and quality control workflows and supports Avantor's own research and development initiatives. Mr. Stone joined Avantor in April 2023 as Executive Vice President, Proprietary Research Products and Materials. Prior to joining Avantor, Mr. Stone served as the President of DuPont's (NYSE: DD) Mobility and Materials segment, a leading provider of engineered polymers, performance resins and advanced solutions serving the electronics, industrial, consumer and transportation markets, from 2016 until November 2022 when DuPont divested the majority of the business. From 2012 until 2015, Mr. Stone served as a Director of Investor Relations for DuPont, during which time he gained extensive experience interacting with institutional investors and analysts. Prior to that, Mr. Stone served as a DuPont Regional Director in Asia, based in Shanghai, China. Mr. Stone presently serves as a member of the board of directors of Ansell Corporation (ASX: ANN), a leading Australian-based global manufacturer of personal protective equipment (PPE), specializing in advanced, high-performance gloves, protective clothing, and safety solutions for healthcare and industrial sectors.

Ms. Dodrill served as President, Global Surgical Solutions & Patient Support Systems at Baxter International, Inc., (NYSE: BAX), a company with a portfolio of diagnostic, critical care, kidney care, nutrition, hospital and surgical products, until October 2022. Previously, Ms. Dodrill worked at Hillrom Holdings, Inc., a company specializing in medical device innovation, from October 2012 until December 2021 when it was acquired by Baxter International, Inc. While with Hillrom, Ms. Dodrill held various positions including President, Global Surgical and Vice President and General Manager of the U.S. Surgical Division. Ms. Dodrill also previously served as Vice President and General Manager of Trumpf Medical Surgical Solutions NA. Ms. Dodrill is a member of the board of directors of Procept BioRobotics (NASDAQ: PRCT), a commercial-stage surgical robotics company focused on developing transformative solutions in urology and currently serves as a member of the Audit and Compensation Committees.

Mr. Zulueta currently serves as CEO of CZ Ventures LLC, which invests in early-stage startups and established practices throughout a range of fields. Mr. Zulueta spent more than three decades in various roles of increasing responsibility with Eli Lilly and Company (NYSE: LLY), a global pharmaceutical company, including as Vice President of Global Marketing, President of Global Oncology and Critical Care Products and, most recently, as President of International responsible for all geographies outside the United States and Canada, from 2017 until his retirement at the end of 2021. Mr. Zulueta also served as a corporate officer and a member of Eli Lilly and Company's Executive Committee. Mr. Zulueta previously served as a member of the board of the European Federation of Pharmaceutical Industries and Associations and the U.S.-Japan Business Council. Mr. Zulueta currently serves as Non-Executive Chairman of the board of directors of Interpharma Investments Limited, the holding company of Zuellig Pharma, one of the largest healthcare services groups in Asia. Mr. Zulueta also serves as a director of Lupin Limited (NSE: LUPIN), a pharmaceutical company that develops and commercializes a wide range of products in the cardiovascular, anti-diabetics, and respiratory segments, and is a member of the Audit and Strategy Committees. Mr. Zulueta previously served as a director of Glooko, Inc., Amarin Corporation (NASDAQ: AMRN), Syneos Health, Inc. (formerly NASDAQ: SYNH) and Calidi Biotherapeutics, Inc. (NYSE: CLDI).

Ms. MacKay served as Senior Vice President, General Counsel and Corporate Secretary of West Pharmaceutical Services, Inc. (NYSE: WST), a leading provider of innovative, high-quality injectable solutions and services from 2020 to 2025. At West Pharmaceuticals, Ms. MacKay led the legal, compliance, data privacy, regulatory, sustainability, enterprise risk, business continuity, real estate and facilities services, and safety functions. Prior to joining West Pharmaceuticals, she served as the Senior Vice President, General Counsel and Corporate Secretary of The Segal Group, a privately held firm specializing in employee benefits and investment consulting, from 2019 to 2020. From 2003 to 2019, Ms. MacKay served in roles of increasing responsibility at Novartis (NYSE: NVS), including Head, U.S. Legal for Novartis Business Services, Deputy Compliance Officer for Novartis Pharmaceuticals Corporation and Lead Counsel for a large business unit. Prior to Novartis, Ms. MacKay practiced securities law at two large public companies and a law firm. Ms. MacKay currently serves as Vice-Chair of the board of the Community Foundation of New Jersey, a non-profit supporting critical needs across New Jersey, and a member of the Compliance, Audit and Risk Committee for BAYADA Home Health Care, a national health care provider.